icon-folder.gif   Conference Reports for NATAP  
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
Impact of Drug Use and Opioid Substitution Therapy on
Hepatitis C Reinfection: The BC Hepatitis Testers Cohort

  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
from Jules: HCV reinfection to IDUs & MSM sexually is a major concern. Clearly reinfection presents one of the biggest barriers to treating HCV & for insurers to cover HCV treatment. This must be addressed in a clear effective way in order to have a chance to eliminate J=HCV in the USA, it creates a barrier to the federal government to address HCV elimination.
Naveed Z Janjua MBBS, MSc, DrPH
for: Islam N1,4, KrajdenM2,4, Shoveller J1,5, Gustafson P3, Gilbert M1,4, Buxton J1,4, Wong J1,4, Tyndall T1,4, Janjua NZ1,4, BC-HTC Team
1. School of Population and Public Health; 2. Department of Pathology and Laboratory Medicine; 3. Department of Statistics, University of British Columbia, Vancouver, Canada;
4. British Columbia Centre for Disease Control, Vancouver, Canada;
5. British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada